Healthcare

Paradigm Announces Launch Of A$77.9 Mn Capital Raise For Clinical Trials

Paradigm Announces Launch Of A$77.9 Mn Capital Raise For Clinical Trials

Paradigm Biopharmaceuticals Limited (ASX: PAR) announced launch of A$77.9 million capital raise anticipated to fund the company’s osteoarthritis (OA) and mucopolysaccharidosis (MPS) programs through...
RAP

ResApp Health Submitted De Novo Application to the FDA For ResAppDx-US

A leading digital health company, ResApp Health Limited (ASX: RAP) has submitted an application to the US Food and Drug Administration (FDA) for De...

Organic Food major Wattle Health Australia issues an update on Blend & Pack Acquisition

Wattle Health Australia Limited (ASX: WHA) is on the journey to becoming known for offering sustainable, organic products of superior quality targeting people across...

MGC Pharmaceuticals Grabs CannEpilTM Import Permit For UK With First Formal Purchase Orders

MGC Pharmaceuticals Ltd (ASX: MXC), a European based specialist medical cannabis biopharma company, on 12 April 2019 announced that it had received a United...
NUH

Audio wearables company, Nuheara launches Direct to Consumer Self Care hearing online platform

Nuheara Limited (ASX: NUH) is a leading audio wearables technology company that develops and provides personal hearing devices based on proprietary and multi-functional intelligent...
Virtus Health Collaborates With Vitrolife And Harrison. AI For Ivy AI Technology

Virtus Health Collaborates With Vitrolife And Harrison. AI For Ivy AI Technology

Virtus Health Limited (ASX: VRT), based in Greenwich, Australia, offers a range of fertility care and related specialised diagnostic and day hospital services in...

Creso Pharma to raise A$5.35 million via a series of secured loans

Creso Pharma Limited (ASX: CPH) is a pharmaceutical company, working in the medical cannabis sector. It aims to improve the lives of both humans...
Imagion Received An Order Related To Cancer Treatment From NewPhase; Stock Surged Up By 8%

Imagion Received An Order Related To Cancer Treatment From NewPhase; Stock Surged Up By...

On 11 April 2019, Imagion Biosystems Limited (ASX: IBX), dedicated to improving healthcare through the earlier detection of cancer, notified the market that NewPhase...
Immuron To Pursue Clinical Development Through FDA For IMM-124E As TD Drug

Immuron To Pursue Clinical Development Through FDA For IMM-124E As TD Drug

Immuron Limited (ASX: IMC) is a biopharmaceutical sector company with operations in Australia. The group is also engaged in the commercialization and development of...
Oneview Announced The Successful Conduct Of A $25m Capital Raising And Upcoming EGM

Oneview Announced The Successful Conduct Of A $25m Capital Raising And Upcoming EGM

On 11th April 2019, patient engagement software company, Oneview Healthcare PLC (ASX: ONE) notified the market that it has successfully conducted a placement to...